Temocillin
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
1–2 g every 12 hoursAcute uncomplicated UTIs: 1 g daily in a single or divided doses
PHARMACOKINETICS
Molecular weight                           :458.4 (as sodium salt) %Protein binding                           :75–85 %Excreted unchanged in urine     : 90 Volume of distribution (L/kg)       :0.23half-life – normal/ESRD (hrs)      :3.1–5.4/28.2 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
30–50 Dose as in normal renal function 10–30 1–2 g daily <10           : 1–2 g every 48 hours DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in GFR <10 mL/min HD                     :Dialysed. Dose as in GFR <10 mL/min HDF/high flux   :Dialysed. Dose as in GFR <10 mL/min CAV/VVHD      :Dialysed. Dose as in GFR=10–30 mL/min IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsTemocillin can reduce the excretion of methotrexate (increased risk of toxicity) ADMINISTRATION
Reconstition
IV: Dissolve in 20 mL water for injection IV infusion
: Dilute in 50–100 mL sodium chloride 0.9%IM: Dissolve in 2 mL water for injection or lidocaine 0.5–1% (volume 2.7 mL) Route
IV, IM Rate of Administration
Slow IV bolus over 3–4 minutes Infusion over 30–40 minutes Comments
Incompatible with proteins, blood products, lipid emulsions and aminoglycosides OTHER INFORMATION
Bleeding has occurred in some patients (more likely in those with renal impairment)20% is removed by haemodialysis and 17–26% by peritoneal dialysis.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home